Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 4:03 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | MAVERICK CAPITAL LTD | 4,958,431 9.2% | 4,958,431 (New Position) | View |
2020-02-14 4:00 pm Unchanged | 13G | Atara Biotherapeutics Inc. ATRA | BRIDGER MANAGEMENT LLC | 2,932,865 5.4% | 0 (Unchanged) | View |
2020-02-13 4:34 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | BAUPOST GROUP LLC | 8,308,900 15.34% | 2,054,268 (+32.84%) | View |
2020-02-12 11:08 am Purchase | 13G | Atara Biotherapeutics Inc. ATRA | VANGUARD GROUP INC | 3,681,701 6.79% | 865,260 (+30.72%) | View |
2020-02-05 11:26 am Purchase | 13G | Atara Biotherapeutics Inc. ATRA | BlackRock Inc. BLK | 4,580,414 8.5% | 1,067,179 (+30.38%) | View |
2019-11-01 4:12 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | BRIDGER MANAGEMENT LLC | 2,932,865 5.5% | 725,948 (+32.89%) | View |
2019-08-12 10:20 am Sale | 13G | Atara Biotherapeutics Inc. ATRA | FMR LLC | 2,457,742 4.621% | -2,816,427 (-53.40%) | View |
2019-07-29 2:27 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | Camber Capital Management LP | 2,950,000 5.55% | 1,050,000 (+55.26%) | View |